Cargando…
The evaluation of dupilumab treatment response in atopic dermatitis patients
OBJECTIVE: This study aims to demonstrate real-life effectiveness of dupilumab treatment in moderate-to-severe atopic dermatitis patients. METHODS: The 14 patients diagnosed with moderate-to-severe atopic dermatitis were included in this study. All of the patients started dupilumab treatment in our...
Autores principales: | Askin, Ozge, Yucesoy, Sera Nur, Serdaroglu, Server |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039099/ https://www.ncbi.nlm.nih.gov/pubmed/33851078 http://dx.doi.org/10.14744/nci.2020.42375 |
Ejemplares similares
-
Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata()()
por: Aşkın, Özge, et al.
Publicado: (2021) -
The Association between the Number of Follicular Stelae and Severity and Treatment Response of Alopecia Areata Cases: A Retrospective Study
por: Gencebay, Güllü, et al.
Publicado: (2022) -
Dupilumab for atopic dermatitis
Publicado: (2019) -
Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
por: Shan, Jinpeng, et al.
Publicado: (2022) -
Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)